Kymera extends growth with $2.1B Sanofi deal
July 09, 2020 at 07:00 AM EDT
French drug giant Sanofi has evolved from one of Kymera Therapeutics Inc.’s investors to a development partner.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|